ArticleAlzheimer's research & therapy2023

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.

Anna M de Kort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.